BOLD vs DG · P/E 0.1, $24.6M cap vs P/E 15, rev $40.61B
Boundless Bio, Inc. Common Stock (BOLD) versus Dollar General Corporation (DG) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Dollar General Corporation (DG) is a discount stores company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported DG revenue for 2025-01-31 was $40.61B. Net income was $1.13B. Revenue was up 5.0% from 2024-02-02 to 2025-01-31. DG currently screens at market cap $22.87B and trailing P/E 14.7.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Not investment advice. Open the BOLD and DG stock pages for the full models.
Not investment advice.